Balyasny Asset Management
ONCT

Balyasny Asset Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Balyasny Asset Management’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-608
Closed -$13K – 2853
2022
Q2 		$13K Buy
+608
New +$13K ﹤0.01% 2099